Spectrascience Inc. has signed an exclusive five-year agreement with Pentax Europe Gmbh to distribute its WavSTAT Optical Biopsy System for use in colorectal cancer screening and diagnosis. PENTAX is a worldwide provider of minimally invasive surgical devices, including flexible endoscopes which are used with the WavSTAT System during screening for colorectal cancer. The agreement, which includes the both the Company's new WavSTAT4 mobile console and the disposable optical biopsy forceps, covers Europe as well as Turkey, Saudi Arabia, and South Africa. The distribution agreement will provide for minimum purchase quantities in specified countries and also gives PENTAX a right of first refusal option for all other countries in the Middle East and Africa.